Clinical predictors of psychotropic medication prescription in children with ASD of the ELENA cohort.

ASD autism children predictors psychotropic

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2023
Historique:
received: 01 02 2023
accepted: 12 06 2023
medline: 7 8 2023
pubmed: 7 8 2023
entrez: 7 8 2023
Statut: epublish

Résumé

Psychotropic drugs are often used to treat behavior problems in ASD with some evidence supporting efficacity (e.g.: risperidone and irritability) but also significant side effects at the short and longer-term. It is then essential to know better the factors associated with the prescription of these medications and potentially implement early behavioral and psychosocial intervention or cognitive remediation before to use medication. We designed a case-control study based on the population of the ELENA cohort to assess the factors associated with early psychotropic drugs use in children with ASD. Externalized behavior symptoms (measured by the Child Behavior Checklist) is the leading risk factor during the first years of follow-up (aOR = 2.8; CI [1.04; 7.67];

Identifiants

pubmed: 37547200
doi: 10.3389/fpsyt.2023.1153543
pmc: PMC10400887
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1153543

Informations de copyright

Copyright © 2023 Geoffray, Baltazar, Michelon, Jurek and Baghdadli.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Child Psychol Psychiatry. 2014 Jan;55(1):49-58
pubmed: 23848399
J Child Adolesc Psychopharmacol. 2014 Nov;24(9):486-93
pubmed: 25329798
Eur Child Adolesc Psychiatry. 2022 Jul;31(7):1-10
pubmed: 33660026
J Autism Dev Disord. 1994 Oct;24(5):659-85
pubmed: 7814313
Psychiatry Res. 2019 Jun;276:203-209
pubmed: 31102885
BMJ Open. 2019 Jun 19;9(6):e026286
pubmed: 31221874
J Autism Dev Disord. 2018 Apr;48(4):1031-1040
pubmed: 28988339
Eur Child Adolesc Psychiatry. 2016 Jun;25(6):649-58
pubmed: 26472118
Autism Res. 2018 Dec;11(12):1690-1700
pubmed: 30380202
JAMA. 2015 Apr 21;313(15):1524-33
pubmed: 25898050
J Clin Med. 2018 Oct 10;7(10):
pubmed: 30308952
J Psychopathol Behav Assess. 2010 Sep;32(3):373-384
pubmed: 20700377
J Am Acad Child Adolesc Psychiatry. 2015 Jul;54(7):580-7
pubmed: 26088663
Acta Psychiatr Scand. 2017 Jan;135(1):8-28
pubmed: 27624381

Auteurs

Marie-Maude Geoffray (MM)

Centre Hospitalier Le Vinatier, Bron, France.
Université Claude Bernard Lyon 1, Lyon, Rhône-Alpes, France.
INSERM U1290 Recherche sur la Performance des Soins (RESHAPE), Lyon, Rhône-Alpes, France.

Matias Baltazar (M)

Centre Hospitalier Le Vinatier, Bron, France.

Cécile Michelon (C)

Université de Montpellier, Montpellier, Languedoc-Roussillon, France.
Centre Hospitalier Universitaire de Montpellier, Montpellier, Languedoc-Roussillon, France.

Lucie Jurek (L)

Centre Hospitalier Le Vinatier, Bron, France.
Université Claude Bernard Lyon 1, Lyon, Rhône-Alpes, France.
INSERM U1290 Recherche sur la Performance des Soins (RESHAPE), Lyon, Rhône-Alpes, France.

Amaria Baghdadli (A)

Université de Montpellier, Montpellier, Languedoc-Roussillon, France.
Centre Hospitalier Universitaire de Montpellier, Montpellier, Languedoc-Roussillon, France.
Centre de Ressources Autisme Languedoc-Roussillon, Montpellier, Languedoc-Roussillon, France.

Classifications MeSH